Cargando…

Editorial: Pharmacological and non-pharmacological therapy for obesity and diabetes - volume II

Detalles Bibliográficos
Autores principales:	Oliveira, Alexandre Gabarra, Carvalho, Bruno Melo, Zweig Rocha, Guilherme
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2023
Materias:	Endocrinology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10623447/ https://www.ncbi.nlm.nih.gov/pubmed/37929042 http://dx.doi.org/10.3389/fendo.2023.1252536

Ejemplares similares

Editorial: The cross-talk between gut microbiota and endogenous metabolites in endocrine diseases, volume II
por: Lu, Van B., et al.
Publicado: (2023)

Editorial: Cardiovascular diseases related to diabetes and obesity – volume II
por: Young, Jamie L., et al.
Publicado: (2022)

Editorial: Effects of pharmacologic therapy for diabetes mellitus on the endocrine system
por: Giagulli, VA, et al.
Publicado: (2022)

Editorial: Pharmacology and treatment methods for NAFLD in the context of diabetes
por: Abu-Farha, Mohamed, et al.
Publicado: (2022)

The Role of LTB4 in Obesity-Induced Insulin Resistance Development: An Overview
por: Callegari, Irineu Otavio Marchiori, et al.
Publicado: (2022)

Editorial: Purinergic pharmacology, Volume II
por: Ciruela, Francisco, et al.
Publicado: (2023)

Editorial: (Osteo)sarcopenia & sarcopenic obesity, volume II
por: Kostoglou-Athanassiou, Ifigenia, et al.
Publicado: (2023)

Pulmonary Hypertension in Obese Mice Is Accompanied by a Reduction in PPAR-γ Expression in Pulmonary Artery
por: Gonçalves, Any Elisa de Souza Schmidt, et al.
Publicado: (2021)

Editorial: COVID-19 and diabetes, volume II
por: Ali, Hamad, et al.
Publicado: (2023)

Editorial: Endocrine and metabolic consequences of childhood obesity, volume II
por: Mazur, Artur, et al.
Publicado: (2023)

Editorial: Advances in the research of diabetic nephropathy, volume II
por: Iizuka, Katsumi, et al.
Publicado: (2023)

Editorial: Advances in the research of diabetic retinopathy, volume II
por: Nawaz, Mohd Imtiaz
Publicado: (2023)

Editorial: Metabolically healthy and unhealthy obese children and adolescents, volume II
por: Xi, Bo, et al.
Publicado: (2022)

Editorial: The Physiology and Pharmacology of Leucine-rich Repeat GPCRs
por: Arey, Brian J., et al.
Publicado: (2016)

Editorial: Diagnosis, prevention and treatment in diabetic nephropathy, volume II
por: Cecchini, Andrea Leonardo, et al.
Publicado: (2023)

Editorial: Obesity, hyperglycemia, and pregnancy: from pathophysiology to clinical practice - volume II
por: Succurro, Elena, et al.
Publicado: (2023)

Diabetes and Aging: From Treatment Goals to Pharmacologic Therapy
por: Longo, Miriam, et al.
Publicado: (2019)

Unlock the Thermogenic Potential of Adipose Tissue: Pharmacological Modulation and Implications for Treatment of Diabetes and Obesity
por: Peng, Xiao-Rong, et al.
Publicado: (2015)

The Role of Hepatocyte Growth Factor (HGF) in Insulin Resistance and Diabetes
por: Oliveira, Alexandre G., et al.
Publicado: (2018)

Editorial: With obesity becoming the new normal, what should we do? ‐Volume II
por: Tziomalos, Konstantinos, et al.
Publicado: (2022)

New Pharmacological Perspectives for the Leptin Receptor in the Treatment of Obesity
por: Roujeau, Clara, et al.
Publicado: (2014)

Editorial: Imaging technology in oncology pharmacological research, volume II
por: Zeng, Qi, et al.
Publicado: (2022)

Editorial: Hydrogen sulfide: Physiology, Pharmacology and Toxicology, Volume II
por: Bian, Jin-Song
Publicado: (2022)

Editorial: Aquatic Pharmacology, Volume II: Pharmacokinetics for Aquatic Species
por: Srisapoome, Prapansak, et al.
Publicado: (2022)

Editorial: Pharmacological approaches targeting neutrophilic inflammation: Volume II
por: Sokolov, Alexey V., et al.
Publicado: (2022)

Editorial: Cancer and bone metastasis, volume II
por: Mandal, Chandi C., et al.
Publicado: (2022)

Editorial: Neuropeptide GPCRs in neuroendocrinology, Volume II
por: Vaudry, Hubert, et al.
Publicado: (2023)

Editorial: The impact of adipose tissue dysfunction on cardiovascular and renal disease, Volume II
por: Sun, Xiaodong, et al.
Publicado: (2023)

Editorial: Chronic inflammation and pharmacological interventions in cardiovascular diseases, volume II
por: Yan, Aiwei, et al.
Publicado: (2023)

Pharmacological approaches to the prevention of type 2 diabetes mellitus
por: Majety, Priyanka, et al.
Publicado: (2023)

Editorial: Translational research in thyroid cancer, Volume II
por: Cheng, Sheue-yann, et al.
Publicado: (2023)

Predictors for pharmacological therapy and perinatal outcomes with metformin treatment in women with gestational diabetes
por: Brzozowska, Malgorzata M., et al.
Publicado: (2023)

Pharmacological inhibitors of β-cell dysfunction and death as therapeutics for diabetes
por: Dalle, Stéphane, et al.
Publicado: (2023)

Editorial: Follicle-stimulating hormone: Fertility and beyond-volume II
por: Simoni, Manuela, et al.
Publicado: (2022)

Editorial: Debates in clinical management in pediatric endocrinology, volume II
por: De Filippo, Gianpaolo, et al.
Publicado: (2023)

Editorial: Polycystic ovary syndrome: mechanism and management—volume II
por: Wang, Yishu, et al.
Publicado: (2023)

Editorial: Assessment of osteoporotic fractures and risk prediction, volume II
por: Xie, Dandan, et al.
Publicado: (2023)

Editorial: Childhood diabetes in low- and middle-income countries: progress, challenges, and actions needed, volume II
por: Geffner, Mitchell E.
Publicado: (2023)

L-T4 Therapy in the Presence of Pharmacological Interferents
por: Benvenga, Salvatore
Publicado: (2020)

Possible Pharmacological Approach Targeting Endoplasmic Reticulum Stress to Ameliorate Leptin Resistance in Obesity
por: Hosoi, Toru, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_o5418ctqndu4thoppspjqc92qu